Korea Bizwire, Author at Be Korea-savvy | Page 136 of 184
Home / Articles posted by Korea Bizwire (Page 136)
Boehringer Ingelheim starts Phase II study of its potential first-in-class oral compound as a treatment for Geographic Atropy

Boehringer Ingelheim starts Phase II study of its potential first-in-class oral compound as a treatment for Geographic Atropy

Ingelheim, Germany, May 6, 2025 (Korea Bizwire) – Boehringer Ingelheim today announces the start of the JADE Phase II clinical study (NCT06769048), investigating the efficacy and safety of BI 1584862 as a potential first-in-class treatment for geographic atrophy (GA).[1]   Geographic atrophy (GA) is an eye disease that can lead to irreversible vision loss.[2] It affects more than [...]

Park Place Technologies Expands Multi-Cloud Services with Acquisition of UK-Based CSI

Park Place Technologies Expands Multi-Cloud Services with Acquisition of UK-Based CSI

Deal Marks One of the Largest in Company History, Significantly Bolstering Park Place’s Managed Services Capabilities CLEVELAND, OH, May 06, 2025 (Korea Bizwire) — Park Place Technologies, the leading global data center and networking optimization firm, has acquired CSI Ltd., a UK-headquartered IT Managed Services Provider (MSP) specializing in hybrid multi-cloud solutions for legacy IBM [...]

Czech Court Temporarily Halts Nuclear Plant Signing with S. Korea: Reports

Czech Court Temporarily Halts Nuclear Plant Signing with S. Korea: Reports

PRAGUE, May 6 (Korea Bizwire) — A Czech court on Tuesday temporarily blocked the government in Prague from signing a multibillion-dollar agreement with South Korea for the construction of two nuclear reactors, according to multiple reports, making it highly unlikely that an official contract will be concluded this week. A South Korean consortium led by [...]

Unionized Seoul Bus Drivers to Resume ‘Work-To-Rule’ Protest After Long Weekend

Unionized Seoul Bus Drivers to Resume ‘Work-To-Rule’ Protest After Long Weekend

SEOUL, May 6 (Korea Bizwire) — Unionized bus drivers in Seoul will resume their “work-to-rule” protest this week following a long holiday weekend, city officials said Tuesday. In a press release, the Seoul Metropolitan Government said the union will launch its collective action early Wednesday and the city will take “special steps” to minimize inconveniences [...]

Ingredion Incorporated Reports Strong First Quarter Results and Improves Full-Year Outlook

Ingredion Incorporated Reports Strong First Quarter Results and Improves Full-Year Outlook

Ingredion Incorporated (NYSE: INGR) headquartered in the suburbs of Chicago, is a leading global ingredient solutions provider serving customers in more than 120 countries. (image courtesy of Ingredion Incorporated) First quarter 2025 reported and adjusted* operating income increased 30% and 26% compared to prior year First quarter 2025 reported and adjusted EPS were $3.00 and $2.97, [...]

SK Telecom Suspends New Subscriber Sign-Ups Amid Data Breach Response

SK Telecom Suspends New Subscriber Sign-Ups Amid Data Breach Response

SEOUL, May 5 (Korea Bizwire) — SK Telecom Co., South Korea’s leading wireless services provider, suspended new subscriber sign-ups nationwide Monday as part of its response to a recent data breach involving the company’s network. The suspension came as the company focused on replacing universal subscriber identity module (USIM) chips for mobile phones after detecting [...]

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a global pharmaceutical leader with a category-defying portfolio, harnessing our generics expertise and stepping up innovation to continue the momentum behind the discovery, delivery, and expanded development of modern medicine. (Image from Teva Pharmaceutical Facebook) The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) [...]

TMC CEO Testifies Before Congress: Deep-Sea Minerals Key to U.S. Industrial Future

TMC CEO Testifies Before Congress: Deep-Sea Minerals Key to U.S. Industrial Future

CEO and Chairman Gerard Barron testified before the House Committee on Natural Resources on “Exploring the Potential of Deep-Sea Mining to Expand American Mineral Production” Mr. Barron highlighted the abundant, unattached polymetallic nodule resource as a platform to secure new supplies of critical minerals essential for U.S. infrastructure, defense, energy, and technology—and to drive reindustrialization [...]